Daily non-political popular news in brief.

Studies show role of age, gender, race and weight on cancer risk and treatment

05-21-2007 · EurekAlert!

While cancer has been studied extensively to determine the major contributing factors for risk and ultimate outcome, many variables still remain and doctors are puzzled by new cases that do not fit "old" protocol. Research presented today at Digestive Disease Week 2007 demonstrates improved results in determining these risks, including the relative "weight" of being heavy on risk for colon cancer; possible risk of cancer surgery among elderly individuals; and how race determines incidence as well as treatment decisions. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

Keywords: studies, show, role, age, gender, race, weight, cancer, risk, treatment, study

« Previous | Next »

Similar news on "Studies show role of age, gender, race and weight on cancer risk and treatment":

Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
08-10-2007 · EurekAlert!
In the first study of how weight may affect school attendance, researchers at the University of Pennsylvania and Temple University have found that overweight children are absent from school on average 20 percent more than their normal-weight peersThe study of more than a thousand 4th, 5th and 6th graders also determined that body mass index is as significant a factor in determining absenteeism from school as age, race, socioeconomic status and gender, formerly the four main predictors.
Similar news · Read more »
Study shows interruption of antiretroviral therapy increases risk of disease and death
11-30-2006 · EurekAlert!
Findings from one of the largest HIV/AIDS therapy studies show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. Researchers affiliated with the Mailman School of Public Health led a large multi-center international study, known as Strategies for Management of Anti-Retroviral Therapies, or SMART, comparing two treatment strategies for people with human immunodeficiency virus. Findings demonstrate the value of continuous antiretroviral therapy.
Similar news · Read more »
Jefferson oncologists show breast cancers to be more aggressive in African-American women
07-09-2007 · EurekAlert!
A study of more than 2,200 women shows that African-Americans have more advanced breast cancer at the time of diagnosis than Caucasians. African-American women tend to have breast cancer tumor types that are more aggressive and have poorer prognoses. The findings are in line with other recent studies, and provide more evidence of the continuing need for early breast cancer screening for African-American women and the development of individual treatment strategies.
Similar news · Read more »
Rural patients' colon and lung cancers diagnosed earlier, Dartmouth research says
11-20-2007 · EurekAlert!
A new study by Dartmouth researchers suggests that urban patients with colorectal and lung cancer are more likely than their rural counterparts to "present at a late stage" -- i.e. to not be seen by a doctor until their cancers are advanced and less treatable. This effect was seen even when the study controlled for other factors associated with late-stage presentation, such as age, race, gender, marital status, income level, and level of education.
Similar news · Read more »
TV's beauty makeovers mask ugly truths
03-23-2007 · EurekAlert!
Fans and critics alike of beauty makeover shows will find something worth debating in a research paper published by University of Alberta philosophy professor Dr. Cressida Heyes. In the March 2007 issue of Feminist Media Studies, Heyes argues that, for all the beautification that takes place on the ABC reality show Extreme Makeover, there are some ugly truths at its core. Feel-good stories of self-transformation are masking messages about the importance of conforming to society’s ideals regarding gender, age, class and race.
Similar news · Read more »
UGA study finds physical, emotional burden of breast cancer lingers for older survivors
04-05-2007 · EurekAlert!
A new study led by a researcher at the University of Georgia College of Public Health finds that even five years after completing treatment, older breast cancer survivors consistently score lower in measures of well-being such as life satisfaction when compared to a control group of women matched for age and socioeconomic status. The findings contrast with studies in younger women, who tend to return to pre-cancer levels of well-being within two years of completing treatment.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Full-term, low-birth-weight babies at significantly greater risk for early respiratory symptoms
05-15-2007 · EurekAlert!
Through age 5, children born at full term with low birth weight show significantly greater risk for developing respiratory symptoms, including wheezing, coughing and pulmonary infections, according to a large longitudinal study on birth weight and development. The children's symptoms grew worse if they were exposed to environmental tobacco smoke.
Similar news · Read more »
Recent studies confirm significant underuse of colorectal cancer screening
12-17-2007 · EurekAlert!
Two recently released studies confirm an alarming reality, that a majority of Americans who should be getting screened for colorectal cancer are not. According to a study in the journal Cancer, among an assessment of Medicare beneficiaries between 1998 and 2004, only 25.4 percent of people were screened, despite Medicare coverage for colorectal cancer screening. Figures released by the Agency for Healthcare Research and Quality show that only half of Americans age 50 and over have had a screening colonoscopy.
Similar news · Read more »
Analysis: Older men treated for early prostate cancer
12-12-2006 · EurekAlert!
An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
Similar news · Read more »